News
-
-
COMMUNIQUÉ DE PRESSE
Original-Research: Jaguar Health Inc (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research initiates coverage on Jaguar Health Inc, recommending a Buy with USD 60.00 price target. Jaguar focuses on plant-based medicines for GI health challenges, with crofelemer as flagship product -
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Jaguar Health to Hold Investor Webcast Thursday, May 15 at 4:15 PM Eastern Regarding Q1 2025 Financials & Corporate Updates
Jaguar Health, Inc. to file Q1 2025 Earnings Report on May 15, 2025 and conduct investor webcast. Focus on pharmaceuticals from rainforest plants for gastrointestinal distress -
-